No Data
No Data
Express News | Knight Therapeutics Announces Filing of New Drug Submission for Qelbree® (Viloxazine) in Canada
Knight Therapeutics Announces Filing of New Drug Submission for Qelbree (Viloxazine) in Canada
Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Is Going Strong But Fundamentals Appear To Be Mixed : Is There A Clear Direction For The Stock?
Analysts Offer Insights on Healthcare Companies: Merus (MRUS), Supernus Pharmaceuticals (SUPN) and Skye Bioscience (SKYE)
Piper Sandler Sticks to Their Hold Rating for Supernus Pharmaceuticals (SUPN)
Screening For Black Friday Bargains In The Stock Market
No Data